Testicular Cancer - Results from #160

Peripubertal presentation of metastatic testicular mixed, nonseminomatous germ cell tumor. November 15, 2023

Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office. November 13, 2023

Testicular cancer in 2023: Current status and recent progress. November 10, 2023

Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. November 8, 2023

Predictors of the development of febrile neutropenia in chemotherapy for advanced germ cell tumors. November 6, 2023

Metastatic Testicular Mixed Germ Cell Tumor Presenting as Posterior Scrotal Pain in the Emergency Department: A Case Report. October 30, 2023

Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis. October 23, 2023

Testicular Cancer: The Unmet Needs of a Younger Generation of Cancer Survivors. October 18, 2023

Germline APC Alterations May Predispose to Testicular Sex Cord-Stromal Tumors. October 16, 2023

Causes of death among patients with testicular cancer during the survivorship. October 16, 2023

Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship. October 12, 2023

Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior. October 6, 2023

Proton Radiation Therapy for Stage IIA/IIB Testicular Seminoma. October 5, 2023

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database. October 2, 2023

Mitochondrial metabolism-related signature depicts immunophenotype and predicts therapeutic response in testicular germ cell tumors. September 27, 2023

Adverse Health Outcomes and Global Quality of Life in Long-term Testicular Cancer Survivors: A longitudinal 30-year perspective. September 25, 2023

SAVE Testis-sparing score: A multicenter retrospective study of a novel predictive tool for quantifying testicular tumors. September 25, 2023

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma. September 21, 2023

Excellent survival in relapsed stage I testicular cancer. September 20, 2023

Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023. September 18, 2023

Page 9 of 95